Table 2.
Drug-Placebo Comparisons Tested in the Meta-analysis Studies
| Medication | No. of Studies Testing Each Medication | Number of Subjects in Drug Group | Number of Subjects in Placebo Group |
|---|---|---|---|
| Nonstimulants/Others | |||
| Atomoxetine | 6 | 425 | 339 |
| Bupropion | 1 | 52 | 20 |
| Modafinil | 3 | 410 | 209 |
| Immediate-release Stimulants | |||
| MAS | 3 | 97 | 95 |
| d-Amp | 1 | 35 | 35 |
| MPH | 10 | 499 | 396 |
| Pemoline | 1 | 21 | 21 |
| d-MPH | 1 | 43 | 41 |
| Long-acting Stimulants | |||
| MAS XR | 2 | 147 | 227 |
| d-Amp ER | 1 | 35 | 35 |
| MPH MR | 2 | 275 | 198 |
| MPH OROS | 3 | 271 | 265 |
| MTS | 2 | 96 | 85 |
| MPH-LA | 1 | 63 | 71 |
Notes: The table includes crossover studies for which the medication and placebo subjects were the same; some studies examined more than 1 medication.